What does C+CURE OPERATIONS do?

C+CURE OPERATIONS is a repair and maintenance company in Wavre. Private Limited, started on 8 September 1989, 1 establishment.

What is the address of C+CURE OPERATIONS?

The registered office of C+CURE OPERATIONS is located at Rue de Genval 20, 1301 Wavre.

Is C+CURE OPERATIONS still active?

Yes. According to the CBE (29 October 2026) C+CURE OPERATIONS is active, legal situation “Normale toestand”, started on 8 September 1989.

Is C+CURE OPERATIONS registered on Peppol?

Yes, C+CURE OPERATIONS is registered on the Peppol network with ID 0208:0438246889.

What is the enterprise number of C+CURE OPERATIONS?

The enterprise number of C+CURE OPERATIONS is BE0438246889.

When was C+CURE OPERATIONS founded?

C+CURE OPERATIONS was founded on 8 September 1989.

Who are the directors of C+CURE OPERATIONS?

According to the 2025 annual accounts, the directors of C+CURE OPERATIONS are: Martin NEYS.

Is C+CURE OPERATIONS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 September 1989; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did C+CURE OPERATIONS make in 2025?

C+CURE OPERATIONS recorded a loss after taxes of € 11,065 in financial year 2025.

What is the revenue of C+CURE OPERATIONS?

As a small company, C+CURE OPERATIONS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -10,534.

C+CURE OPERATIONS (Private Limited) - Wavre

Dossier C+CURE OPERATIONS, printed on 29 October 2026 from databakkes.be/en/0438246889/c-cure-operations. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

23 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

C+CURE OPERATIONS from Wavre, company number BE0438246889, closed financial year 2025 with a result of € -11,065 after tax. For that financial year C+CURE OPERATIONS recorded a gross margin of € -10,534 and equity of € 4,591. Compared with financial year 2024, the result moved from € 997 to € -11,065. The company made a loss. The buffer shrank hard: equity is 71 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Shrank hard

€ 4,591

▼ 71% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -11,065

▼ still € 997 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 5,442

▲ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -15,409.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,841

▼ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 7,029 Gross margin 2022: € 7,029 First fiscal year in the series	€ 20,621 Gross margin 2023: € 20,621 ▲ 193% vs 2022 (€ 7,029) Favourable step	€ 2,085 Gross margin 2024: € 2,085 ▼ 90% vs 2023 (€ 20,621) Unfavourable step	€ -10,534 Gross margin 2025: € -10,534 ▼ € 12,619 vs 2024 (€ 2,085) Unfavourable step	▼ € 12,619
Profit after taxes	€ 6,325 Profit after taxes 2022: € 6,325 First fiscal year in the series	€ 19,824 Profit after taxes 2023: € 19,824 ▲ 213% vs 2022 (€ 6,325) Favourable step	€ 997 Profit after taxes 2024: € 997 ▼ 95% vs 2023 (€ 19,824) Unfavourable step	€ -11,065 Profit after taxes 2025: € -11,065 ▼ € 12,062 vs 2024 (€ 997) Unfavourable step	▼ € 12,062
Equity	€ -5,165 Equity 2022: € -5,165 First fiscal year in the series	€ 14,659 Equity 2023: € 14,659 ▲ € 19,824 vs 2022 (€ -5,165) Favourable step	€ 15,656 Equity 2024: € 15,656 ▲ 7% vs 2023 (€ 14,659) Favourable step	€ 4,591 Equity 2025: € 4,591 ▼ 71% vs 2024 (€ 15,656) Unfavourable step	▼ 71%
Total debts	€ 5,833 Total debts 2022: € 5,833 First fiscal year in the series	€ 3,048 Total debts 2023: € 3,048 ▼ 48% vs 2022 (€ 5,833) Favourable step	€ 5,788 Total debts 2024: € 5,788 ▲ 90% vs 2023 (€ 3,048) Unfavourable step	€ 1,841 Total debts 2025: € 1,841 ▼ 68% vs 2024 (€ 5,788) Favourable step	▼ 68%
Cash	€ 668 Cash 2022: € 668 First fiscal year in the series	€ 791 Cash 2023: € 791 ▲ 18% vs 2022 (€ 668) Favourable step	€ 4,134 Cash 2024: € 4,134 ▲ € 3,343 vs 2023 (€ 791) Favourable step	€ 5,442 Cash 2025: € 5,442 ▲ 32% vs 2024 (€ 4,134) Favourable step	▲ 32%
Retained profit	€ -25,165 Retained profit 2022: € -25,165 First fiscal year in the series	€ -5,341 Retained profit 2023: € -5,341 ▲ € 19,824 vs 2022 (€ -25,165) Favourable step	€ -4,344 Retained profit 2024: € -4,344 ▲ € 997 vs 2023 (€ -5,341) Favourable step	€ -15,409 Retained profit 2025: € -15,409 ▼ € 11,065 vs 2024 (€ -4,344) Unfavourable step	▼ € 11,065
Balance sheet total	€ 668 Balance sheet total 2022: € 668 First fiscal year in the series	€ 17,707 Balance sheet total 2023: € 17,707 ▲ € 17,039 vs 2022 (€ 668) Unchanged	€ 21,444 Balance sheet total 2024: € 21,444 ▲ 21% vs 2023 (€ 17,707) Unchanged	€ 6,432 Balance sheet total 2025: € 6,432 ▼ 70% vs 2024 (€ 21,444) Unchanged	▼ 70%

Key figures of C+CURE OPERATIONS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to C+CURE OPERATIONS?

What happened at C+CURE OPERATIONS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: loss of € 11,065 (▼ € 12,062 vs 2024). Source: NBB ↗
2019 Martin NEYS became a director. NBB
Sep 12, 1989 New establishment in Wavre. KBO
Sep 8, 1989 Start of the company according to the CBE. KBO

In short

From € 6,325 profit in 2022 to € 11,065 loss in 2025.

Paid € 849 in corporate taxes since 2022.

Best year ever: 2023, with € 19,824 profit.

Original PDFs at the National Bank ↗

Management

Martin NEYS

C+CURE OPERATIONS

Behind C+CURE OPERATIONS is Martin NEYS.

Directors

According to the 2025 annual accounts

Martin NEYS

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Genval 20

1301 Wavre

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 23 companies are registered at this address.

All companies at this address →

SHOPPINFO

PETROGESTION

€ -550 gross margin · 2025

SECO - INVEST

€ 39,946 gross margin · 2025

INTERNATIONAL SERVICES & ADVICES

€ 59,926 gross margin · 2025

ERPICUM

€ 334,624 gross margin · 2025

+18 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0438.246.889

VAT number

BE 0438.246.889

Registered office

Rue de Genval 20, 1301 Wavre

Names & denominations

C+CURE OPERATIONS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

8 September 1989

Peppol

Active · Active since 16 Feb 2026

Activities · NACE

Installatie van industriële machines, toestellen en werktuigen

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Adviesbureaus op het gebied van public relations en communicatie

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

C+CURE OPERATIONS

Warning lights

Financials

What happened to C+CURE OPERATIONS?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions